MBX Biosciences | ARS: Annual Report to Security Holders
MBX Biosciences | DEFA14A: Others
MBX Biosciences | DEF 14A: Definitive information statements
MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Pescovitz Ora H.
MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Hoerter Steven L.
MBX Biosciences | 3: Initial statement of beneficial ownership of securities-Director Hoerter Steven L.
MBX Biosciences | 8-K: Current report
MBX Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
MBX Biosciences | 10-K: FY2024 Annual Report
MBX Biosciences | 8-K: MBX Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Director GORDON CARL L
MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Director ORBIMED ADVISORS LLC
MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Hawryluk P. Kent
MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Bartram Richard
MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Azoulay Salomon
MBX Biosciences | 8-K: Current report
MBX Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Wellington Management Group LLP(9.22%),Wellington Group Holdings LLP(9.22%), etc.
MBX Biosciences | 10-Q: Quarterly report
MBX Biosciences | 8-K: MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
MBX Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-P. Kent Hawryluk(5.55%)